Michaela J. Day, BSc, MSc, PhD

Clinical Scientist
United Kingdom Health Security Agency, United Kingdom

Poster(s):

• (P68) Gonorrhoea Undetected Resistance Laboratory Study (GURLS): a case-finding study for ceftriaxone-resistant Neisseria gonorrhoeae in England
  Tuesday, July 25, 2023

  16:00 – 18:00 CST

• (P69) Reduced susceptibility of pharyngeal Neisseria gonorrhoeae infections to current recommended therapeutics in England and Wales using national surveillance data (GRASP)
  Tuesday, July 25, 2023

  16:00 – 18:00 CST

• (P217) Low prevalence of asymptomatic Mpox virus in men attending sexual health services for HIV pre-exposure prophylaxis in England
  Tuesday, July 25, 2023

  16:00 – 18:00 CST

• (P247) Mycoplasma genitalium Antimicrobial Resistance Surveillance (MARS): protocol for a national surveillance programme in England
  Tuesday, July 25, 2023

  16:00 – 18:00 CST

• (P72) Neisseria gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) for cases of disseminated gonococcal infection (DGI)
  Tuesday, July 25, 2023

  16:00 – 18:00 CST

• (P255) Detection of gyrA mutations in Mycoplasma genitalium from individuals who failed treatment
  Wednesday, July 26, 2023

  16:00 – 18:00 CST